Nanocomposite carrier for double loading of peptides and chemotherapeutic drugs and its preparation and application
A chemotherapeutic drug and nano-composite technology, which is applied in the direction of drug combination, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problem of difficulty in effectively penetrating cell membranes, instability, and large toxic and side effects of chemotherapy drugs, etc. problems, to achieve the effect of reducing dosage and side effects, enhancing penetration and good dispersibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0060] Example 1: Preparation of mesoporous silica-dendrimer nanocomposite carrier loaded with Bcl-2 function conversion peptide (NuBCP9) and chemotherapeutic drug DOX simultaneously
[0061] (1) Take 2g of cetyltrimethylammonium chloride and 0.18g of triethanolamine in a reaction vessel, add 80ml of deionized water at 95°C to dissolve and stir for 1h;
[0062] (2) Slowly add 1.5ml tetraethyl orthosilicate dropwise to the reaction system, continue to stir for 2h and then centrifuge, wash with a large amount of ethanol and water respectively, to obtain mesoporous silica nanoparticles containing surfactant;
[0063] (3) The mesoporous silica nanoparticles containing surfactant obtained in step (2) are placed in methanol solution containing 1% sodium chloride, ultrasonically dispersed and washed on a rotary mixer for 12 hours at room temperature, and repeated for 4 times, vacuum drying after washing with water to obtain mesoporous silica nanoparticles whose surface groups are hyd...
Embodiment 2
[0075] Example 2: Analysis of the cell-entry ability of mesoporous silica-dendrimer composite nanocarriers double-loaded with NuBCP9 anti-cancer small peptide and chemotherapy drug DOX
[0076] After co-incubating 1 μg / ml DOX and its corresponding concentration NuBCP-9-FITC and NuBCP-9-FITC@MSNs~G5~DOX with Bcl-2 stably transfected cells HeLa-Bcl2 for 10 h, the mitochondrial far-red probe was used to locate the mitochondria, Nuclei were localized with 1 μg / ml DAPI dye for confocal imaging analysis.
[0077] See the confocal image of the drug-loaded drug-loaded nano-drug complex prepared in Example 2 for hela-Bcl2 tumor cells to penetrate into the cell and distribute in the cell. Figure 7 . Free NuBCP-9 small peptides cannot enter the interior of Hela cells, and free DOX drugs can freely penetrate cancer cells and enter the nucleus; however, under the transport of composite nanocarriers, both NuBCP9 small peptides and DOX can enter the interior of cells and reach their respec...
Embodiment 3
[0078] Example 3: Analysis of the ability of mesoporous silica-dendrimer composite nanocarriers double-loaded with NuBCP9 anticancer small peptide and chemotherapeutic drug DOX to inhibit the proliferation of cancer cells
[0079] Prepare DOX concentrations of 0.1, 0.5, 1, 2, 5, 10 μg / ml or corresponding NuBCP-9 concentrations containing NuBCP-9, DOX, N9+DOX, N9@M~G5, N9@M~G5~DOX After co-cultivating with HeLa-Bcl2 cells for 48 hours, the cell viability was detected by MTT, and the cytotoxicity of different groups of drugs was obtained.
[0080] For the experimental research on the cytotoxicity of the dual drug-loaded nanocomposite carrier prepared in Example 3 to hela-Bcl2 tumor cells, see Figure 8 . Because the free small peptide itself cannot enter the cell, it has no killing effect on tumor cells; however, under the carrier of the composite nanocarrier, N9 can enter the cell and exert the function of inhibiting the growth of cancer cells. At a dose corresponding to 5 μg / ...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle size | aaaaa | aaaaa |
pore size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com